Trademark: 87554273
Status Date
Tuesday, June 16, 2020
Registration Number
6080490
Registration Date
Tuesday, June 16, 2020
Filing Date
Thursday, August 3, 2017
Published for Opposition
Tuesday, December 12, 2017
5 pharmaceutical products for the treatment of cancer; pharmaceutical products, namely, EZH2 inhibitory drugs
Oct 19, 2022
Assignment Of Ownership Not Updated Automatically
Jun 16, 2020
Registered-Principal Register
May 14, 2020
Notice Of Acceptance Of Statement Of Use E-Mailed
May 13, 2020
Allowed Principal Register - Sou Accepted
Apr 29, 2020
Statement Of Use Processing Complete
Apr 14, 2020
Use Amendment Filed
Apr 29, 2020
Case Assigned To Intent To Use Paralegal
Apr 14, 2020
Teas Statement Of Use Received
Jan 29, 2020
Notice Of Approval Of Extension Request E-Mailed
Jan 27, 2020
Sou Extension 4 Granted
Jan 27, 2020
Sou Extension 4 Filed
Jan 27, 2020
Sou Teas Extension Received
Jun 14, 2019
Notice Of Approval Of Extension Request E-Mailed
Jun 12, 2019
Sou Extension 3 Granted
Jun 12, 2019
Sou Extension 3 Filed
Jun 12, 2019
Sou Teas Extension Received
Jan 19, 2019
Notice Of Approval Of Extension Request E-Mailed
Jan 15, 2019
Sou Extension 2 Granted
Jan 15, 2019
Sou Extension 2 Filed
Jan 15, 2019
Sou Teas Extension Received
Jun 16, 2018
Notice Of Approval Of Extension Request E-Mailed
Jun 14, 2018
Sou Extension 1 Granted
Jun 14, 2018
Sou Extension 1 Filed
Jun 14, 2018
Sou Teas Extension Received
Feb 6, 2018
Noa E-Mailed - Sou Required From Applicant
Dec 12, 2017
Official Gazette Publication Confirmation E-Mailed
Dec 12, 2017
Published For Opposition
Nov 22, 2017
Notification Of Notice Of Publication E-Mailed
Nov 6, 2017
Approved For Pub - Principal Register
Nov 6, 2017
Assigned To Examiner
Aug 8, 2017
New Application Office Supplied Data Entered
Aug 7, 2017
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
